Compositions and their uses directed to huntingtin

Details for Australian Patent Application No. 2007210038 (hide)

Owner Isis Pharmaceuticals Inc.

Inventors Freier, Susan M.

Agent Wrays

Pub. Number AU-A-2007210038

PCT Pub. Number WO2007/089611

Priority 60/836,290 07.08.06 US; 60/762,954 26.01.06 US

Filing date 26 January 2007

Wipo publication date 9 August 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/089611 Priority application(s): WO2007/089611

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007210044-Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith

2007210034-RNA silencing agents for use in therapy and nanotransporters for efficient delivery of same